Clinical Trial Update: Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study assessing glycemic effects, safety, and tolerability of metformin delayed release in adults with Type 2 Diabetes Mellitus; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin Delayed-Release (metformin delayed-release)

Snippet

Sponsor: Elcelyx Therapeutics, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2018-04-27